发明公开
EP3128048A1 FIBRONECTIN TYPE III DOMAIN BASED SCAFFOLD COMPOSITIONS, METHODS AND USES
审中-公开
澳大利亚FIBRONECTIN-TYP-III-DOMAIN BASIERENDEGERÜSTZUSAMMENSETZUNGEN,VERFAHREN UND VERWENDUNG
- 专利标题: FIBRONECTIN TYPE III DOMAIN BASED SCAFFOLD COMPOSITIONS, METHODS AND USES
- 专利标题(中): 澳大利亚FIBRONECTIN-TYP-III-DOMAIN BASIERENDEGERÜSTZUSAMMENSETZUNGEN,VERFAHREN UND VERWENDUNG
-
申请号: EP16176749.6申请日: 2009-10-27
-
公开(公告)号: EP3128048A1公开(公告)日: 2017-02-08
- 发明人: JACOBS, Steven , O'NEIL, Karyn
- 申请人: Janssen Biotech, Inc.
- 申请人地址: 800/850 Ridgeview Drive Horsham, PA 19044 US
- 专利权人: Janssen Biotech, Inc.
- 当前专利权人: Janssen Biotech, Inc.
- 当前专利权人地址: 800/850 Ridgeview Drive Horsham, PA 19044 US
- 代理机构: Carpmaels & Ransford LLP
- 优先权: US110120P 20081031
- 主分类号: C40B30/04
- IPC分类号: C40B30/04 ; C07K7/06 ; C07K14/00 ; C07H21/04
摘要:
A protein scaffold based on a consensus sequence of fibronectin type III (FN3) proteins, such as the tenth FN3 repeat from human fibronectin (human Tenascin), including isolated nucleic acids that encode a protein scaffold, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices. In particular, protein scaffold molecules binding to IgG have been identified as useful for diagnostic and/or therapeutic applications.
公开/授权文献
信息查询